ADC Therapeutics SA (ADCT)
Healthcare
Biotechnology
1.10 $
-5.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns ADC Therapeutics SA (ADCT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 78.9% of the shares are freely tradable; institutional investors hold 67.6%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
67.6%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
13.4%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
78.9%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
5.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
127Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Redmile Group, LLC | 12.16 | 15,470,502 | -1.3 | 03/31/2026 |
| TCG Crossover Management, LLC | 8.96 | 11,390,175 | +0.0 | 03/31/2026 |
| Prosight Management, LP | 6.53 | 8,300,000 | -2.1 | 03/31/2026 |
| BlackRock Inc | 4.91 | 6,250,747 | +15.2 | 03/31/2026 |
| Eventide Asset Management, LLC | 4.48 | 5,701,655 | +69.5 | 03/31/2026 |
| Nantahala Capital Management, LLC | 4.40 | 5,597,433 | +2.2 | 03/31/2026 |
| Morgan Stanley - Brokerage Accounts | 3.00 | 3,812,582 | +1.1 | 03/31/2026 |
| Point72 Asset Management, L.P. | 2.66 | 3,382,129 | -32.6 | 03/31/2026 |
| Millennium Management LLC | 2.45 | 3,119,154 | +849.7 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Eventide Healthcare & Life Sciences I | 4.48 | 5,701,655 | +69.5 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.